Mysterious uncoupled clinical symptoms and interferon signature in Sjögren's syndrome: limitations of current approaches for unravelling complexity?
- PMID: 31504960
- DOI: 10.1093/rheumatology/kez381
Mysterious uncoupled clinical symptoms and interferon signature in Sjögren's syndrome: limitations of current approaches for unravelling complexity?
Comment on
-
Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren's syndrome in the JOQUER randomized trial.Rheumatology (Oxford). 2020 Jan 1;59(1):107-111. doi: 10.1093/rheumatology/kez242. Rheumatology (Oxford). 2020. PMID: 31237947 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
